UnknownNCT04986735
Prospective Cohort Study of Children With GSD1b Receiving Empagliflozin
Studying Glycogen storage disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hong Kong Children's Hospital
- Principal Investigator
- Mei Kwun KwokHong Kong Children's Hospital
- Intervention
- Empagliflozin(drug)
- Enrollment
- 11 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2023
Study locations (1)
- Hong Kong Children's Hospital, Hong Kong, Hong Kong
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04986735 on ClinicalTrials.govOther trials for Glycogen storage disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07459582Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage DiseaseConnecticut Children's Medical Center
- RECRUITINGNANCT06852612Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type IInsel Gruppe AG, University Hospital Bern
- RECRUITINGNCT06843330Accuracy of Lactate Meter in GSDIaConnecticut Children's Medical Center
- RECRUITINGNCT06396546'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'Institute of Liver and Biliary Sciences, India
- RECRUITINGNCT04454216GSD VI and GSD IX Natural HistoryDuke University